Target intelligence / Profile preview

Novel transcript, sense intronic to Ankyrin repeat domain 54 (ENSG00000297940)

Target: ENSG00000297940
Molecular classification: Other (noncoding RNA/transcript), sense intronic transcript

Overview

This entry designates a novel noncoding RNA gene transcribed from within an intron of the Ankyrin repeat domain 54 (ANKRD54) locus, in the sense (coding) direction. There is currently no scientific evidence that this transcript encodes a protein or has a recognized physiological or pathological role, and it is not considered a therapeutic target in drug discovery or clinical applications.

Other names: ENSG00000297940

Biological functions

Unknown

Disease associations

None established

Beyond the preview

Go deeper on Novel transcript, sense intronic to Ankyrin repeat domain 54 (ENSG00000297940).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, sense intronic to Ankyrin repeat domain 54 (ENSG00000297940).

Explore the full profile